Nationwide study of clinical and molecular features of hereditary non-polyposis colorectal cancer (HNPCC) in Latvia

Anticancer Research

Volumn 27, Issue 1 B, 2007, Pages 653-658

  Irmejs, Arvids ^a   Borosenko, Viktors ^a   Melbarde Gorkusa, Inga ^a   Gardovskis, Andris ^a   Bitina, Marianna ^a   Kurzawski, Grzegorz ^b   Suchy, Janina ^b   Gorski, Bohdan ^b   Gardovskis, Janis ^a  

^a RIGA STRADINS UNIVERSITY   (Latvia)

^b POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

HNPCC; MLH1; MSH2; MSH6

Indexed keywords

DNA; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6;

ADULT; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER SCREENING; CLINICAL FEATURE; COLORECTAL CANCER; DATA ANALYSIS; DIAGNOSTIC ACCURACY; DISEASE COURSE; DNA DETERMINATION; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; IMMUNOHISTOCHEMISTRY; LATVIA; MAJOR CLINICAL STUDY; MALE; MISMATCH REPAIR; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

CARRIER PROTEINS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA MISMATCH REPAIR; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; FAMILY HEALTH; FEMALE; HUMANS; LATVIA; MALE; MUTATION; MUTS HOMOLOG 2 PROTEIN; NUCLEAR PROTEINS; PEDIGREE;

EID: 33847728255     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Cancer Patient Registry of Latvia 3: 2004.
2. Kurzawski G et al: Mutation analysis of MLH1 and MSH2 genes performed by denaturing high-performance liquid chromatography. J Biochem Biophys Methods 51(1): 89-100, 2002.
3. Vasen H: Erfelijke tumoren. Richtlijnen voor diagnostiek en preventie. Stichting Opsporing Erfelijke Tumoren and Vereniging klinische Genetica Nederland Werkgroep Klinische Oncogenetica 21: 2001.
4. Kurzawski G et al: Germline MSH2 and MLH1 mutational spectrum in HNPCC families from Poland and the Baltic States. J Med Genet 39(10): E65, 2002.
5. Holmberg M et al: Mutation sharing, predominant involvement of the MLH1 gene and description of four novel mutations in hereditary nonpolyposis colorectal cancer. Mutations in brief no. 144. Hum Mutat 11(6): 482, 1998.
6. Vasen HF et al: The International Collaborative Group on hereditary non-polyposis colorectal cancer (ICG-HNPCC). Dis Colon Rectum 34(5): 424-425, 1991.
7. Park JG et al: Suspected hereditary nonpolyposis colorectal cancer: International Collaborative Group on hereditary non-polyposis colorectal cancer (ICG-HNPCC) criteria and results of genetic diagnosis. Dis Colon Rectum 42(6): 710-716, 1999.
8. Park JG et al: Suspected HNPCC and Amsterdam criteria II: evaluation of mutation detection rate, an international collaborative study. Int J Colorectal Dis 17(2): 109-114, 2002.
9. Boesze P, Elsakov P, Foretova L, Gardovskis J, Haites N, Lubinski J, Mecklin JP, Moeslein G, Neumann H, Ponder B, Sobol H, Vasen H and Weber W: Progress report of EC project QLRI -1999 - 00063; Development of network of cancer family syndrome registries in Eastern Europe. Standards of a model registry of cancer family syndromes for Eastern Europe 2000; www.republika.pl/genetyka/standards.htm, 2000.
10. Aarnio M et al: Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 81(2): 214-218, 1999.
11. Evans DG et al: Incidence of hereditary non-polyposis colorectal cancer in a population-based study of 1137 consecutive cases of colorectal cancer. Br J Surg 84(9): 1281-1285, 1997.
12. Olsson L and Lindblom A: Family history of colorectal cancer in a Sweden county. Fam Cancer 2(2): 87-93, 2003.
13. Katballe N et al: Frequency of hereditary non-polyposis colorectal cancer in Danish colorectal cancer patients. Gut 50(1): 43-51, 2002.
14. Mecklin JP et al: Frequency of hereditary nonpolyposis colorectal cancer. A prospective multicenter study in Finland. Dis Colon Rectum 38(6): 588-593, 1995.
15. Cornaggia M et al: Low incidence of hereditary nonpolyposis colorectal cancer syndrome in a selected area of the Lombardy Cancer Registry. Tumori 86(6): 439-444, 2000.
16. Peel DJ et al: Characterization of hereditary nonpolyposis colorectal cancer families from a population-based series of cases. J Natl Cancer Inst 92(18): 1517-1522, 2000.
17. Foulkes WD et al: The founder mutation MSH2*1906G->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population. Am J Hum Genet 71(6): 1395-1412, 2002.
18. Raedle J et al: Frequency of the Amsterdam criteria in a regional German cohort of patients with colorectal cancer. Z Gastroenterol 40(8): 56156-56158, 2002.
19. Irmejs A, Gardovskis A, Borosenko V, Bitina M, Aigare D, Kurzawski G, Suchy J, Gorski B and Gardovskis J: Hereditary Colorectal Cancer (CRC) Program in Latvia. Hereditary Cancer in Clin Prac 1(1): 49-53, 2003.
20. Kladny J, Myrhoj T, Kurzawski G, Jakubowska A, Debniak T, Petriczko W, Kozlowski M, Al-Amawi T, Brzosko M, Flicinski J, Jawien A, Banaszkiewicz Z, Rychter P and Lubinski J: Nuclear pedigree criteria of suspected HNPCC. Hered Cancer Clin Prac 1(1): 34-38, 2003.
21. Kaufmanis A and Zvirbule I: Hereditary nonpolyposis colorectal cancer. Jums, Kolegi 8: 28, 1997.
22. de Leon MP et al: Hereditary colorectal cancer in the general population: from cancer registration to molecular diagnosis. Gut 45(1): 32-38, 1999.
23. Vasen HF et al: New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 116(6): 1453-1456, 1999.
24. Lubinski J and Suchy J: Zespol MSH6, in Nowotwory dziedziczne 2002. Profilaktyka, diagnostyka, leczenie. Termedia, Poznan, pp. 55-58, 2003.
25. Wagner A et al: Atypical HNPCC owing to MSH6 germline mutations: analysis of a large Dutch pedigree. J Med Genet 38(5): 318-322, 2001.
26. Wu Y et al: Association of hereditary nonpolyposis colorectal cancer-related tumors displaying low microsatellite instability with MSH6 germline mutations. Am J Hum Genet 65(5): 1291-1298, 1999.
27. Berends MJ et al: Molecular and clinical characteristics of MSH6 variants: an analysis of 25 index carriers of a germline variant. Am J Hum Genet 70(7): 26-37, 2002.
28. Samowitz WS et al: The colon cancer burden of genetically defined hereditary nonpolyposis colon cancer. Gastroenterology 121(4): 830-838, 2001.
29. Percesepe A et al: Molecular screening for hereditary nonpolyposis colorectal cancer: a prospective, population-based study. J Clin Oncol 19(19): 3944-3950, 2001.
30. Aaltonen LA: Molecular epidemiology of hereditary nonpolyposis colorectal cancer in Finland. Recent Results Cancer Res 154: 306-311, 1998.
31. Salovaara R et al: Population-based molecular detection of hereditary nonpolyposis colorectal cancer. J Clin Oncol 18(11): 2193-2200, 2000.